Literature DB >> 24424178

Diagnosis and classification of autoimmune parathyroid disease.

Corrado Betterle1, Silvia Garelli2, Fabio Presotto3.   

Abstract

Hypoparathyroidism (HP) is clinically characterized by the presence of hypocalcemia, usually associated with specific signs and symptoms that depend on how severe and chronic the disease becomes. HP is usually caused by surgical removal of all four parathyroids, while other forms are rarer. Autoimmune HP can occur as an isolated disease or as part of an autoimmune polyendocrine syndrome. Here we review what is known about parathyroid gland autoimmunity, focusing on recently-proposed parathyroid autoantibody markers, and particularly those directed against NACHT leucine-rich-repeat protein 5 and calcium-sensing receptor. We also describe the clinical characteristics of HP and design a diagnostic algorithm for autoimmune HP.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune hypoparathyroidism; Autoimmune polyendocrine syndromes; Calcium-sensing receptor autoantibodies; Chronic hypoparathyroidism; NACHT leucine-rich-repeat protein 5 autoantibodies

Mesh:

Substances:

Year:  2014        PMID: 24424178     DOI: 10.1016/j.autrev.2014.01.044

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

1.  Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.

Authors:  Noriko Makita; Takao Ando; Junichiro Sato; Katsunori Manaka; Koji Mitani; Yasuko Kikuchi; Takayoshi Niwa; Masanori Ootaki; Yuko Takeba; Naoki Matsumoto; Atsushi Kawakami; Toshihisa Ogawa; Masaomi Nangaku; Taroh Iiri
Journal:  JCI Insight       Date:  2019-04-18

Review 2.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

3.  Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up.

Authors:  Ramona Dadu; Theresa E Rodgers; Van A Trinh; Elizabeth Helen Kemp; Trisha D Cubb; Sapna Patel; Julie M Simon; Elizabeth M Burton; Hussein Tawbi
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

Review 4.  Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism.

Authors:  Susan Martin; Kristina Chen; Nimanee Harris; Montserrat Vera-Llonch; Alan Krasner
Journal:  Adv Ther       Date:  2019-06-10       Impact factor: 3.845

5.  Could Fahr's Syndrome Have More Than One Simultaneous Etiology?

Authors:  Gabriele Palu; Samia T Moraes; Gabriela Romaniello; Luis O Zatorre; Luiza K Seixas; Rafael Miyazima; Gustavo Lenci Marques
Journal:  Cureus       Date:  2021-12-11

Review 6.  Epidemiology and Diagnosis of Hypoparathyroidism.

Authors:  Bart L Clarke; Edward M Brown; Michael T Collins; Harald Jüppner; Peter Lakatos; Michael A Levine; Michael M Mannstadt; John P Bilezikian; Anatoly F Romanischen; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2016-03-04       Impact factor: 5.958

7.  Primary hypoparathyroidism presenting as basal ganglia calcification secondary to extreme hypocalcemia.

Authors:  Edite Marques Mendes; Lúcia Meireles-Brandão; Carla Meira; Nuno Morais; Carlos Ribeiro; Diana Guerra
Journal:  Clin Pract       Date:  2018-01-08

8.  Hypoparathyroidism with Fahr's syndrome: A case report and review of the literature.

Authors:  Yuan-Yuan Zhou; Ying Yang; Hong-Mei Qiu
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

Review 9.  Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management.

Authors:  Dalal S Ali; Karel Dandurand; Aliya A Khan
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.